Targacept Presents Data from Highly Successful Phase 2b Trial of...

Full story: Freshnews

Targacept, Inc. , a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line ...

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Celexa, Citalopram Discussions

Topic	Updated	Last By	Comments
Celexa and hair loss? (Mar '07)	19 hr	kat	51
Time of day to take Citalopram? (Jun '08)	22 hr	Lloyd	8
Stopped taking citalopram 20mg after 3 days Am... (May '08)	Sat	Missi	97
Sexual roller-coaster on Citalopram (Nov '06)	Sat	Christopher	62
How long does it take to kick in?	Sat	mani	5
New to celexa ... jaw clenching and loss of app... (Apr '07)	Sat	mani	53
Weight loss on Citalopram? (Jun '08)	Sat	mani	18